Clinical trials
Withdrawn Hemophilia A trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Boston VA Research Institute, Inc. | 1 |
| Cangene Corporation | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| Emory University | 1 |
| Margaret Ragni | 1 |
| Spark Therapeutics, Inc. | 1 |
| University of Minnesota | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 10 |
| Blood Coagulation Disorders | 2 |
| Anemia, Sickle Cell | 1 |
| Blood Coagulation Disorders, Inherited | 1 |
| Coagulation Protein Disorders | 1 |
| Genetic Diseases, Inborn | 1 |
| Genetic Diseases, X-Linked | 1 |
| Hematologic Diseases | 1 |
| Hemophilia B | 1 |
| Hemorrhage | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.